Explosion of Senescence-Targeting: Clinical Trials Expected within a Couple of Years

The Senescence field \”has completely exploded\”

Aubrey de Grey, founder of SENS, expects that the senescence-targeting industry will be able to conduct Phase 3 trials in \”a few years\”.

Source:

Senescence field has “completely exploded”